Education
About Us
Working with TipRanks
Follow Us
Astrana Health Inc. (ASTH)
:ASTH
ASTH Stock Chart & Stats
$32.99
$0.06(0.19%)
At close: 4:00 PM EST
$32.99
$0.06(0.19%)
Day’s Range― - ―
52-Week Range$20.12 - $43.30
Previous CloseN/A
Volume92.25K
Average Volume (3M)515.24K
Market Cap
$1.14B
Enterprise Value$1.81B
Total Cash (Recent Filing)$463.45M
Total Debt (Recent Filing)$1.09B
Price to Earnings (P/E)119.9
Beta1.09
Next Earnings
Feb 19, 2026EPS Estimate
0.1Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)0.01
Shares Outstanding50,155,613
10 Day Avg. Volume703,036
30 Day Avg. Volume515,237
Financial Highlights & Ratios
PEG Ratio-1.16
Price to Book (P/B)2.11
Price to Sales (P/S)0.74
P/FCF Ratio34.04
Enterprise Value/Market Cap1.58
Enterprise Value/Revenue0.62
Enterprise Value/Gross Profit6.14
Enterprise Value/Ebitda16.69
Forecast
1Y Price Target
$32.67Price Target Upside-0.97% Downside
Rating ConsensusModerate Buy
Number of Analyst Covering6
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
Bulls Say, Bears Say
Bulls Say
Free Cash Flow And LeverageStrong free cash flow generation year-to-date has put ASTH on a path to reaching post-Prospect leverage targets well ahead of schedule.
Partnership And ExpansionThe company announced a strategic partnership with Intermountain Health to expand its operations across southern Nevada.
Valuation OpportunityASTH's depressed valuation at less than 7x consensus FY26 EBITDA is seen as an opportunity and is viewed as one of the highest upside vehicles to play a bullish FY26 MA thesis.
Bears Say
Guidance ReductionThe company lowered FY25 Adj EBITDA guide $15m at the midpoint, related to the pushed back timing of a capitated contract implementation.
Investor ConfidenceThe FY26 EBITDA bar for ASTH is low and implies very little investor confidence in the full-risk contract conversion delays that management is assuming will be effective in 1Q26.
Price Target AdjustmentThe price target was moved from $40 to $35, based on a 2026 EV/EBITDA-NCI target of 10.6x.
Astrana Health News
ASTH FAQ
What was Astrana Health Inc.’s price range in the past 12 months?
Astrana Health Inc. lowest stock price was $20.12 and its highest was $43.30 in the past 12 months.
What is Astrana Health Inc.’s market cap?
Astrana Health Inc.’s market cap is $1.14B.
When is Astrana Health Inc.’s upcoming earnings report date?
Astrana Health Inc.’s upcoming earnings report date is Feb 19, 2026 which is in 73 days.
How were Astrana Health Inc.’s earnings last quarter?
Astrana Health Inc. released its earnings results on Nov 06, 2025. The company reported $0.01 earnings per share for the quarter, missing the consensus estimate of $0.466 by -$0.456.
Is Astrana Health Inc. overvalued?
According to Wall Street analysts Astrana Health Inc.’s price is currently Overvalued.
Does Astrana Health Inc. pay dividends?
Astrana Health Inc. does not currently pay dividends.
What is Astrana Health Inc.’s EPS estimate?
Astrana Health Inc.’s EPS estimate is 0.1.
How many shares outstanding does Astrana Health Inc. have?
Astrana Health Inc. has 50,155,613 shares outstanding.
What happened to Astrana Health Inc.’s price movement after its last earnings report?
Astrana Health Inc. reported an EPS of $0.01 in its last earnings report, missing expectations of $0.466. Following the earnings report the stock price went down -23.441%.
Which hedge fund is a major shareholder of Astrana Health Inc.?
Currently, no hedge funds are holding shares in ASTH
Astrana Health Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Moderate Buy
Average Price Target:
$32.67 (-0.97% Downside)
$32.67 (-0.97% Downside)
Blogger Sentiment
Bullish
ASTH Sentiment 70%
Sector Average ―
Sector Average ―
Hedge Fund Trend
Increased
By 233.2K Shares
Last Quarter.
Last Quarter.
Crowd Wisdom
Very Negative
Last 7 Days ▼ 5.2%
Last 30 Days ▼ 4.4%
Last 30 Days ▼ 4.4%
Technicals
SMA
Negative
20 days / 200 days
Momentum
-46.33%
12-Months-Change
Fundamentals
Return on Equity
1.29%
Trailing 12-Months
Asset Growth
74.05%
Trailing 12-Months
Company Description
Astrana Health Inc.
Astrana Health (ASTH) is a biotechnology company focused on developing innovative healthcare solutions that enhance patient outcomes. Operating primarily within the healthcare and pharmaceutical sectors, Astrana Health specializes in the research and development of novel therapeutics, diagnostic tools, and digital health platforms. The company's core products include advanced therapies targeting chronic illnesses and personalized medicine solutions, aimed at improving patient care and optimizing treatment efficacy.
ASTH Company Deck
ASTH Earnings Call
Q3 2025
0:00 / 0:00
Earnings Call Sentiment|Positive
Astrana Health's earnings call highlighted significant revenue and EBITDA growth, successful integration of Prospect Health, and technological advancements. However, delays in full risk contract transitions and potential Medicaid headwinds presented challenges. The positive aspects, including strong financial performance and strategic partnerships, were more prominent.View all ASTH earnings summariesASTH Stock 12 Month Forecast
Average Price Target
$32.67
▼(-0.97% Downside)
Technical Analysis
Healthcare Services
―
Pediatrix Medical Group
―
Select Medical
―
US Physical Therapy
―
Aveanna Healthcare Holdings
―
Ownership Overview
47.33% Insiders
18.23% Mutual Funds
7.78% Other Institutional Investors
5.09% Public Companies and
Individual Investors
Options Prices
Currently, No data available
---